Security Snapshot

HARTE HANKS INC - Common Stock (HHS) Institutional Ownership

CUSIP: 416196202

13F Institutional Holders and Ownership History from Q4 2015 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

19

Shares (Excl. Options)

1.13MFull value: 1,127,055 · shares · 30 Sep 2026

Price

$4.55

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-889,407
Value change
-$949,809
Number of holders
19
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
7,428,895
SEC-reported price per share
$3.96
Insider filing price
$3.96
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HHS - HARTE HANKS INC - Common Stock is tracked under CUSIP 416196202.
  • 19 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 22 to 19 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $4.5MFull value: $4,497,753 · USD · 30 Jun 2026
    to
    $5.1MFull value: $5,100,669 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 19 institutions filings for Q3 2026.

Open SEC evidence

Security key

416196202

13F reference period

Q3 2026

13F holders

19

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
HHS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosenbach Gary Stephen 29% $9,639,789 2,118,635 Gary S. Rosenbach 17 Apr 2023
Radoff Bradley Louis 5.7% $914,646 423,447 Radoff Bradley Louis 14 Aug 2026
Kent Lake PR LLC 2.5% $897,411 180,203 Kent Lake PR LLC 31 Dec 2024
As of 30 Sep 2026, 19 institutional investors reported holding
1.13MFull value: 1,127,055 · shares · 30 Sep 2026
shares of HARTE HANKS INC - Common Stock (HHS). This represents 15% of the company’s total
7.43MFull value: 7,428,895 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 16 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 3.4% 252,858 0% $1,150,504
JBF Capital, Inc. 2.9% 212,500 0.13% $966,875
Krilogy Financial LLC 2% 152,004 0.02% $664,257
RAFFLES ASSOCIATES LP 1.2% 87,757 0.34% $399,294
Ursa Fund Management, LLC 0.94% 70,000 0.07% $318,500
CSS LLC/IL 0.88% 65,183 0.01% $296,583
RENAISSANCE TECHNOLOGIES LLC 0.87% 64,700 0% $294,385
GEODE CAPITAL MANAGEMENT, LLC 0.74% 54,988 0% $250,270
DIMENSIONAL FUND ADVISORS LP 0.57% 42,621 0% $193,926
VANGUARD FIDUCIARY TRUST CO 0.41% 30,619 0% $139,316
STATE STREET CORP 0.36% 26,497 0% $120,561
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 12,834 0% $58,395
GSA CAPITAL PARTNERS LLP 0.17% 12,779 0% $58,000
Empowered Funds, LLC 0.14% 10,500 0% $47,775
Vanguard Global Advisers, LLC 0.03% 1,918 0% $8,727
Triumph Capital Management 0% 86 0% $391

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
41
Headline period
Q3 2026
Rows shown
1-25 of 41
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,127,055 $5,100,669 -$949,809 $4.55 19
2026 Q2 2,082,548 $4,497,753 +$7,072 $2.16 22
2026 Q1 2,078,376 $4,788,142 +$3,776 $2.27 22
2025 Q4 2,076,132 $6,259,961 -$125,547 $3.01 23
2025 Q3 2,117,837 $7,770,288 -$471,768 $3.71 22
2025 Q2 2,239,999 $8,915,272 -$18,623 $3.98 23
2025 Q1 2,242,065 $10,760,915 -$869,931 $4.80 23
2024 Q4 2,410,425 $12,412,138 -$1,323,602 $5.15 23
2024 Q3 2,650,020 $19,731,218 -$1,811,108 $7.44 25
2024 Q2 2,560,223 $20,788,107 +$2,612,713 $8.12 30
2024 Q1 2,358,456 $17,639,492 -$542,274 $7.48 26
2023 Q4 2,433,546 $16,529,955 +$124,528 $6.79 26
2023 Q3 2,419,675 $15,751,446 -$2,367,715 $6.51 23
2023 Q2 2,825,760 $15,482,732 -$1,833,384 $5.48 30
2023 Q1 3,103,331 $29,200,550 -$1,452,853 $9.41 32
2022 Q4 3,207,842 $37,498,779 +$1,313,107 $11.69 40
2022 Q3 3,156,793 $35,220,000 +$9,452,042 $11.15 35
2022 Q2 2,305,041 $29,208,249 -$697,052 $12.74 17
2022 Q1 2,368,141 $17,927,000 -$1,205,317 $7.57 13
2021 Q4 2,515,646 $19,125,000 +$8,588,000 $7.60 9
2020 Q4 0 $0 -$460,412 $3.96 0
2020 Q3 221,723 $460,412 -$5,971,588 $2.08 5
2020 Q2 2,120,919 $6,448,000 -$281,207 $3.04 18
2020 Q1 2,213,794 $3,475,000 +$944,826 $1.57 18
2019 Q4 1,611,624 $5,769,000 +$34,300 $3.58 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .